With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

The Tesla Test-How AI is Changing How We Search Video
The Tesla Test: How AI is Changing How We Search Video
October 7, 2025

In this episode of Secured, Mike Monsive sits down once again with Idan Koren, EVP of Marketing at Verkada, to discuss how artificial intelligence is transforming the landscape of physical security, operational efficiency, and the broader business of technology. The conversation begins with Verkada’s groundbreaking integration of natural language search in video surveillance —…

Read More
adult learning
Finding the North Star For Adult Learning: How UTI Is Redefining Upskilling for the Modern Workforce
October 7, 2025

In a world where rapid technological change is redefining how we live, work, and learn, the demand for skilled labor and lifelong learning has never been higher. From electric vehicle repair to advanced diagnostics in healthcare, the U.S. faces a widening talent gap in the skilled trades and allied health industries. According to the National…

Read More
child advocacy
Child Advocacy in Action: How CASA Sustains Impact Through Volunteerism and Vision
October 7, 2025

Across the United States, roughly 390,000 children are living in foster care, each facing the challenges of navigating the child welfare and court systems. Nonprofits working in this space carry the dual responsibility of supporting children’s emotional needs while also sustaining the funding and partnerships that make child advocacy possible. This raises a pressing…

Read More
women empowerment
Creating a Playbook for Pro Athlete’s Families: How Ladies Playbook Champions Empowerment for Women Off the Field
October 7, 2025

In today’s world of rapid transitions—career moves, geographic relocations, and shifting personal identities—community has become more than a comfort; it’s a lifeline. Studies show that strong social ties can increase well-being, reduce stress, and even improve physical health. For those navigating high-pressure environments, like the partners of professional athletes, having access to a supportive,…

Read More